Spots Global Cancer Trial Database for adult teratoma
Every month we try and update this database with for adult teratoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment | NCT00453310 | Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | sunitinib malat... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors | NCT00301782 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... carboplatin cisplatin etoposide phosp... vincristine sul... | 16 Years - | National Cancer Institute (NCI) | |
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | NCT00432094 | Childhood Germ ... Ovarian Cancer Teratoma | carboplatin etoposide ifosfamide paclitaxel thiotepa autologous hema... Mesna filgrastim | 10 Years - 69 Years | Masonic Cancer Center, University of Minnesota | |
Combination Chemotherapy in Treating Men With Germ Cell Cancer | NCT00003643 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide paclitaxel | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | NCT00453232 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... pegfilgrastim cisplatin etoposide | 18 Years - 40 Years | National Cancer Institute (NCI) | |
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin | NCT00423852 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin ifosfamide paclitaxel autologous hema... peripheral bloo... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | NCT00002931 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl... | 16 Years - 120 Years | City of Hope Medical Center | |
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors | NCT00470366 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | pegfilgrastim cisplatin ifosfamide paclitaxel | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
Combination Chemotherapy in Treating Men With Germ Cell Cancer | NCT00003643 | Extragonadal Ge... Teratoma Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide paclitaxel | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |